Improving the self-report of medication adherence problems in HIV
改善艾滋病毒药物依从性问题的自我报告
基本信息
- 批准号:8012668
- 负责人:
- 金额:$ 37.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAnti-Retroviral AgentsCardiovascular DiseasesCaringChinese PeopleChronicCognitiveComorbidityComprehensionDataDevelopmentDiabetes MellitusDiagnosisDiseaseDoseElectronic drug monitoringEventFrequenciesGoalsGrantHIVHealthIndividualInterventionJudgmentLanguageLinkMeasuresMental DepressionMethodsMissionMonitorOutcomePatient Self-ReportPatientsPerformancePersonsPharmaceutical PreparationsPhysiciansProcessProviderPsychologistPsychometricsQuestionnairesReportingResearchResearch PersonnelRetrievalSamplingScienceScientistSiteSurveysTechniquesTest ResultTestingValidity and ReliabilityWorkantiretroviral therapyclinical carecohortcompliance behavioreffective interventionelectronic dataexperienceimprovedinnovationinsightmedication compliancenovelpillpreconditioningpublic health relevanceresponsetool
项目摘要
DESCRIPTION (provided by applicant): Despite the availability of one pill once daily treatment for HIV, poor adherence with HIV antiretroviral therapy (ART) clearly continues to be widespread. It is also clear that non-infectious comorbidity such as diabetes and cardiovascular disease is increasingly common in persons with HIV, and that medications required for these other conditions further complicate patients' adherence efforts. Unfortunately, clinicians and researchers have yet to develop inexpensive and accurate methods to diagnose medication adherence problems. Objective methods such as electronic data monitoring are expensive and impractical in clinical care, and there are few well-tested, standardized, accurate methods for self report of medication adherence. Our inability to accurately assess adherence by self report is an important problem, because until we can accurately diagnose adherence problems, for all of a patient's medications, it will not be possible to focus interventions to improve adherence on those who most need them. The long term goal of this research is to link the accurate and timely diagnosis of medication adherence problems with customized treatments that are patient and medication specific. The overall objective of this application, which is the next step toward attainment of our long term goal, is to develop a small set of well-tested items that can be used by clinicians and researchers to diagnose medication adherence problems in persons with HIV. Our central hypothesis is that patients usually cannot remember individual dosing events when they self-report, they estimate. We argue that the rigorous cognitive testing that we plan will produce questionnaire items that are congruent with the actual cognitive processes which patient use to recall and report adherence events, and will thus be optimally accurate. The rationale for choosing this approach is that that the application of methods used by psychologists and cognitive scientists to understand how information is encoded and recalled will provide new insights to the science of medication self-report, and provide important new tools for both clinicians and researchers. The proposed research is relevant to the NIH's mission poor adherence with medications for chronic conditions like HIV is a serious, worldwide problems, and because the accurate identification of medication adherence problems is a precondition for efficient and effective intervention. Guided by strong preliminary data, this R01 proposal has three specific aims: 1) Use in depth cognitive testing to develop optimal medication self-report item sets, 2) Conduct psychometric testing, and 3) Conduct construct validity testing. The approach is innovative because rigorous cognitive testing has not yet been used to optimize the quality of adherence self-report. The proposed research is significant because valid, standardized items for the self-report of medication adherence, across all of a patient's medications, are critically needed for both clinical care and research. Although this proposal focuses on persons with HIV disease, because our testing will focus both on ART and on other non-ART medications, our findings should be generalizable to all persons with chronic conditions.
PUBLIC HEALTH RELEVANCE: Achieving optimal health outcomes for persons with HIV requires that they adhere not only with antiretroviral medications, but also with medications for non-infectious conditions such as diabetes. We propose to develop and validate a small set of self-report items that can be used to identify persons with adherence problems so that they can be efficiently targeted for interventions. Although this proposal focuses on persons with HIV disease, the items we develop should be usable for adherence assessment for medications for persons with any chronic condition.
描述(由申请人提供):尽管可以每天一次服用一粒药丸来治疗艾滋病毒,但艾滋病毒抗逆转录病毒治疗(ART)的依从性差显然仍然很普遍。同样清楚的是,非感染性合并症,如糖尿病和心血管疾病,在艾滋病毒感染者中越来越常见,而这些其他疾病所需的药物治疗进一步使患者的依从性工作复杂化。不幸的是,临床医生和研究人员还没有开发出廉价和准确的方法来诊断药物依从性问题。客观的方法,如电子数据监测是昂贵的,不切实际的临床护理,并有一些良好的测试,标准化,准确的方法自我报告服药依从性。我们无法通过自我报告准确评估依从性是一个重要的问题,因为在我们能够准确诊断依从性问题之前,对于所有患者的药物,将不可能集中干预措施来改善那些最需要它们的人的依从性。这项研究的长期目标是将药物依从性问题的准确和及时诊断与患者和药物特定的定制治疗联系起来。该应用程序的总体目标是实现我们的长期目标的下一步,是开发一套小的经过良好测试的项目,可供临床医生和研究人员用于诊断艾滋病毒感染者的药物依从性问题。他们估计,我们的中心假设是,患者在自我报告时通常无法记住个体给药事件。我们认为,严格的认知测试,我们计划将产生的问卷项目,是一致的实际认知过程中,患者使用的回忆和报告的依从性事件,因此将是最佳的准确性。选择这种方法的理由是,应用心理学家和认知科学家用来理解信息是如何编码和回忆的方法,将为药物自我报告科学提供新的见解,并为临床医生和研究人员提供重要的新工具。拟议的研究与NIH的使命有关,因为对艾滋病毒等慢性病的药物依从性差是一个严重的全球性问题,并且因为准确识别药物依从性问题是有效干预的先决条件。在强有力的初步数据的指导下,R01提案有三个具体目标:1)使用深度认知测试来开发最佳的药物自我报告项目集,2)进行心理测量测试,3)进行结构效度测试。这种方法是创新的,因为严格的认知测试尚未被用于优化依从性自我报告的质量。拟议的研究是重要的,因为有效的,标准化的项目,自我报告的药物依从性,在所有的病人的药物,是迫切需要的临床护理和研究。虽然这项建议的重点是艾滋病毒感染者,因为我们的测试将集中在抗逆转录病毒疗法和其他非抗逆转录病毒疗法的药物,我们的研究结果应该是普遍适用于所有慢性病患者。
公共卫生关系:要使艾滋病毒感染者获得最佳健康结果,他们不仅要坚持使用抗逆转录病毒药物,而且要坚持使用治疗糖尿病等非传染性疾病的药物。我们建议开发和验证一小部分自我报告项目,可用于识别有依从性问题的人,以便他们可以有效地进行干预。虽然这项建议的重点是艾滋病毒感染者,但我们开发的项目应可用于任何慢性病患者的药物依从性评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IRA B WILSON其他文献
IRA B WILSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IRA B WILSON', 18)}}的其他基金
Aging, comorbid conditions, and health care utilization in persons with HIV
艾滋病毒感染者的老龄化、合并症和医疗保健利用
- 批准号:
8714607 - 财政年份:2014
- 资助金额:
$ 37.74万 - 项目类别:
Aging, comorbid conditions, and health care utilization in persons with HIV
艾滋病毒感染者的老龄化、合并症和医疗保健利用
- 批准号:
9229569 - 财政年份:2014
- 资助金额:
$ 37.74万 - 项目类别:
Improving the diagnosis and treatment of medication adherence problems in HIV
改善艾滋病毒药物依从性问题的诊断和治疗
- 批准号:
8012911 - 财政年份:2010
- 资助金额:
$ 37.74万 - 项目类别:
Nudging Doctors to Collaborate with Pharmacists to Improve Medication Adherence
鼓励医生与药剂师合作以提高用药依从性
- 批准号:
8050423 - 财政年份:2010
- 资助金额:
$ 37.74万 - 项目类别:
Improving the self-report of medication adherence problems in HIV
改善艾滋病毒药物依从性问题的自我报告
- 批准号:
8288882 - 财政年份:2010
- 资助金额:
$ 37.74万 - 项目类别:
Improving the diagnosis and treatment of medication adherence problems in HIV
改善艾滋病毒药物依从性问题的诊断和治疗
- 批准号:
8301720 - 财政年份:2010
- 资助金额:
$ 37.74万 - 项目类别:
Improving the diagnosis and treatment of medication adherence problems in HIV
改善艾滋病毒药物依从性问题的诊断和治疗
- 批准号:
8659494 - 财政年份:2010
- 资助金额:
$ 37.74万 - 项目类别:
相似海外基金
RESISTANCE OF HIV-1 TO ANTI-RETROVIRAL AGENTS
HIV-1 对抗逆转录病毒药物的耐药性
- 批准号:
3030975 - 财政年份:1993
- 资助金额:
$ 37.74万 - 项目类别:
POLYMERICS DELIVERY SYSTEMS FOR ANTI-RETROVIRAL AGENTS
抗逆转录病毒药物的聚合物递送系统
- 批准号:
3489187 - 财政年份:1990
- 资助金额:
$ 37.74万 - 项目类别:
DEVELOPMENTAL VIROLOGY RESEARCH--RESISTANCE TO ANTI-RETROVIRAL AGENTS
发育病毒学研究——抗逆转录病毒药物的耐药性
- 批准号:
2335293 - 财政年份:
- 资助金额:
$ 37.74万 - 项目类别: